Parkinson's drug holiday: can a week off meds reveal the Disease's true face?
NCT ID NCT06192823
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether it's possible and safe for people with early-stage Parkinson's disease to stop their medication for one week while being monitored with brain scans and wearable sensors. Twenty participants were followed to see how their symptoms and brain activity changed off meds. The goal was to find better ways to measure the disease itself, not just the effect of drugs, which could help future trials of treatments that aim to slow or stop Parkinson's.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?